Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1

Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1

We previously demonstrated that epigallocatechin-3-gallate (EGCG) synergizes with the immunomodulatory agent glatiramer acetate (GA) in eliciting anti-inflammatory and neuroprotective effects in the relapsing-remitting EAE model. Thus, we hypothesized that mice with chronic EAE may also benefit from...

Full description

Bibliographic Details
Main Authors: Janssen, Antonia, Fiebiger, Sebastian, Bros, Helena, Hertwig, Laura, Romero-Suarez, Silvina, Hamann, Isabell, Chanvillard, Coralie, Bellmann-Strobl, Judith, Paul, Friedemann, Millward, Jason M., Infante-Duarte, Carmen
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482710/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482710/

Similar Items